TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex

Immunity
H HsuD V Goeddel

Abstract

The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD. Here, we show that TRADD interacts strongly with RIP, another death domain protein that was shown previously to associate with Fas antigen. We also show that RIP is a serine-threonine kinase that is recruited by TRADD to TNFR1 in a TNF-dependent process. Overexpression of the intact RIP protein induces both NF-kappa B activation and apoptosis. However, expression of the death domain of RIP Induces apoptosis, but potently inhibits NF-kappa B activation by TNF. These results suggest that distinct domains of RIP participate in the TNF signaling cascades leading to apoptosis and NF-kappa B activation.

References

May 1, 1992·Immunology Today·L A Tartaglia, D V Goeddel
Jan 1, 1992·Immunologic Research·J RotheW Lesslauer
Oct 25, 1991·Proceedings of the National Academy of Sciences of the United States of America·L A TartagliaD V Goeddel
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M LewisD V Goeddel
Mar 10, 1995·Science·S Nagata, P Golstein
Feb 24, 1995·Cell·D Thanos, T Maniatis
Sep 10, 1993·Cell·L A TartagliaD V Goeddel
Mar 1, 1996·The Journal of Biological Chemistry·A M ChinnaiyanV M Dixit
Oct 1, 1995·Trends in Cell Biology·P VandenabeeleW Fiers

❮ Previous
Next ❯

Citations

Mar 26, 1999·European Journal of Immunology·E DudleyM Lenardo
Jul 13, 2000·Microscopy Research and Technique·M J Smyth, R W Johnstone
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K KosaiT Nakamura
May 9, 2000·Biochemical and Biophysical Research Communications·F OzawaM W Büchler
Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
May 21, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Hana Zelová, Jan Hošek
Jun 10, 2010·Cellular and Molecular Life Sciences : CMLS·Sreerupa Challa, Francis Ka-Ming Chan
Nov 5, 1998·International Journal of Clinical & Laboratory Research·M Muzio
May 10, 2013·Molecules and Cells·Haeryung LeeSoochul Park
May 30, 2009·Apoptosis : an International Journal on Programmed Cell Death·Tanja KitevskaChristine J Hawkins
Jan 6, 2011·Apoptosis : an International Journal on Programmed Cell Death·Hyun Ho Park
Nov 1, 2005·Cancer Metastasis Reviews·Peter J Reddig, Rudy L Juliano
Jan 30, 2013·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Hui Yu
Nov 1, 2011·Immunologic Research·Jianke ZhangMathew Farabaugh
Jul 21, 2011·Pathology Oncology Research : POR·Zsuzsanna DunaiRudolf Mihalik
Oct 7, 2011·Protein & Cell·Jianghong Man, Xuemin Zhang
Oct 14, 2003·Bioorganic & Medicinal Chemistry Letters·Jie-Fei ChengAlex Nadzan
Feb 14, 2004·Cellular Immunology·Rita N BárciaJulie D McLeod
Apr 16, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ahter D SanliogluSalih Sanlioglu
Jan 20, 2004·Pharmacology & Therapeutics·Zodwa DlaminiMakhosazana Zungu
Nov 24, 1999·The American Journal of Medicine·P SaikumarM A Venkatachalam
Aug 26, 1998·Biochimica Et Biophysica Acta·J CaiD P Jones
Jan 22, 2003·Biochemical and Biophysical Research Communications·Hanna LindgrenTomas Leanderson
Jul 3, 2003·Experimental Cell Research·Huey-Wen ShyuHung Li
Apr 26, 2003·Mechanisms of Ageing and Development·Sudhir GuptaSastry Gollapudi
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paula C Ashe, Mark D Berry
Jun 17, 2000·Progress in Neurobiology·K J BanasiakG G Haddad
Feb 13, 2001·Experimental Hematology·G Rozenfeld-GranotG Rechavi
Apr 9, 2002·Experimental Hematology·Xiaoxia Li, George R Stark
Feb 20, 1999·Cancer Letters·E C ShinS J Kim
Mar 19, 2002·Cellular Signalling·David J MacEwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis